CryoPort Announces New CryoPort Express(TM) Staging Facility Established in India

Initial Shipments to Facility Allow for 24-Hour Response Time for India-Based Customers

LAKE FOREST, CA -- (MARKET WIRE) -- 11/12/08 -- CryoPort, Inc. (OTCBB: CYRX) today announced that it has established a CryoPort Express(TM) staging facility near Delhi, India. The completion of an agreement with a local technical support entity was fundamental to establishing this capability.

Sending shippers for staging at this site will allow CryoPort to provide 24-hour response times for its customers in India. This will provide a key step as CryoPort moves towards full recycling capabilities within the region.

Peter Berry, CEO of CryoPort, commented, "With an increasing demand for shipments to, from and within India, we believe it is important to establish capabilities to provide this service for our customers. We expect shipments to the Delhi, Mumbai and Bangalore areas to be the highest level of activity, and we will be well positioned to grow with our customers."

To be added to the CryoPort Investor email list, please email edward@carpedminc.com with CYRX in the subject line.

About CryoPort, Inc.

CryoPort (www.cryoport.com) develops leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the testing, research and end user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment.

"SAFE HARBOR"

This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact:
Stuart Fine
Carpe DM, Inc.
908-469-1788

Released November 12, 2008